TOP TIERMARKET NEWSWIRE
News & sentiment

KEROS THERAPEUTICS I (KROS) — News & AI sentiment

KEROS THERAPEUTICS I (KROS) news roundup. 5 stories aggregated over the last 30 days. Average 30-day sentiment is 61.4/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $10K and 4 sales totalling $101K — net selling of $91K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
5
avg sentiment 61.4/100
Insider net (90d)
$91K
1 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

KROS news in the last 24 hours, 7 days, 30 days and 90 days

How much KROS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowKROS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days561.4/100KROS headlines →
Last 90 days2358.6/100KROS headlines →

Latest stories on KROS

Sep 29
Sep 29
Sep 29
Sep 29
Keros Begins Phase 2 Rinvatercept Trial in DMD
TipRanks56 · neutralproduct/pr
Sep 28
Sep 28
Sep 28
Sep 28
Sep 28
Sep 10
Sep 8
Sep 8
Sep 8
Sep 8
Sep 8
Sep 8
Aug 14
Aug 11
Aug 3
Aug 3
Jul 30
Jul 30
Jul 30
Jul 22
Jul 17
Open KROS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →